R1 Therapeutics, Inc. Raises $80.5M From Co-founder

R1 Therapeutics, Inc. raises $80.5M Series A+ led by Co-Founder.

Participants in this funding round include both existing and new investors, further solidifying the company’s financial backing.

R1 Therapeutics develops therapies for kidney disease. The company is led by CEO Krishna Polu.

Company	R1 Therapeutics, Inc.
Round	Series A+
Amount	$80.5M
Lead Investor	Co-Founder
Founders	Krishna Polu
Sectors	biopharmaceutical